X4 Pharmaceuticals, Inc Quarterly Current Federal Tax Expense (Benefit) in USD from Q1 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
X4 Pharmaceuticals, Inc quarterly Current Federal Tax Expense (Benefit) history and growth rate from Q1 2018 to Q1 2024.
  • X4 Pharmaceuticals, Inc Current Federal Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
Current Federal Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.